

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.50703619 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.76494572 |
| 3 | mannose metabolic process (GO:0006013) | 4.50543452 |
| 4 | response to muramyl dipeptide (GO:0032495) | 4.39551617 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12053097 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.12053097 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05059652 |
| 8 | histone H3-K36 demethylation (GO:0070544) | 3.93115193 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.83235567 |
| 10 | positive thymic T cell selection (GO:0045059) | 3.78302854 |
| 11 | thymic T cell selection (GO:0045061) | 3.74826885 |
| 12 | response to peptidoglycan (GO:0032494) | 3.70402291 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62142241 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.52404953 |
| 15 | tolerance induction (GO:0002507) | 3.43909350 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37913538 |
| 17 | T cell selection (GO:0045058) | 3.31451478 |
| 18 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.30232012 |
| 19 | germinal center formation (GO:0002467) | 3.27628202 |
| 20 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.26728886 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26201211 |
| 22 | detection of bacterium (GO:0016045) | 3.25120801 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.24351649 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.22767695 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.22767695 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.22767695 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.22767695 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.22767695 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.22767695 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.21655693 |
| 31 | signal complex assembly (GO:0007172) | 3.19227723 |
| 32 | detection of other organism (GO:0098543) | 3.16083137 |
| 33 | histone H4 deacetylation (GO:0070933) | 3.15557657 |
| 34 | negative regulation of myotube differentiation (GO:0010832) | 3.10635926 |
| 35 | histone H3 deacetylation (GO:0070932) | 3.09974480 |
| 36 | apoptotic process involved in morphogenesis (GO:0060561) | 3.07623555 |
| 37 | regulation of ARF protein signal transduction (GO:0032012) | 3.04634663 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 2.99981508 |
| 39 | negative T cell selection (GO:0043383) | 2.99421109 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 2.99360022 |
| 41 | positive T cell selection (GO:0043368) | 2.99113908 |
| 42 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.98321294 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.96194483 |
| 44 | regulation of ARF GTPase activity (GO:0032312) | 2.95444303 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95276901 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90058968 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 2.89707863 |
| 48 | activation of Rac GTPase activity (GO:0032863) | 2.87447616 |
| 49 | histone H3-K9 demethylation (GO:0033169) | 2.84740571 |
| 50 | histone lysine demethylation (GO:0070076) | 2.80854053 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77882003 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.77291489 |
| 53 | regulation of leukocyte degranulation (GO:0043300) | 2.72897018 |
| 54 | negative regulation of cell size (GO:0045792) | 2.71937797 |
| 55 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.71517500 |
| 56 | leukocyte aggregation (GO:0070486) | 2.71482658 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70919105 |
| 58 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.70057665 |
| 59 | embryonic process involved in female pregnancy (GO:0060136) | 2.69071593 |
| 60 | activation of JUN kinase activity (GO:0007257) | 2.67174998 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66035356 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 2.65232642 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64877980 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.64613072 |
| 65 | histone demethylation (GO:0016577) | 2.62670846 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.62638516 |
| 67 | modulation by virus of host process (GO:0019054) | 2.62552242 |
| 68 | modulation by symbiont of host cellular process (GO:0044068) | 2.61491966 |
| 69 | cell-cell junction maintenance (GO:0045217) | 2.60978492 |
| 70 | T cell migration (GO:0072678) | 2.58034974 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55470369 |
| 72 | response to laminar fluid shear stress (GO:0034616) | 2.55193506 |
| 73 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54673376 |
| 74 | Peyers patch development (GO:0048541) | 2.54673376 |
| 75 | barbed-end actin filament capping (GO:0051016) | 2.54637454 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.51815348 |
| 77 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50591192 |
| 78 | detection of external biotic stimulus (GO:0098581) | 2.50294036 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.49694655 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48702492 |
| 81 | pinocytosis (GO:0006907) | 2.48218334 |
| 82 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47862439 |
| 83 | negative regulation of innate immune response (GO:0045824) | 2.47042402 |
| 84 | activation of MAPKKK activity (GO:0000185) | 2.45419737 |
| 85 | response to type I interferon (GO:0034340) | 2.43903771 |
| 86 | mature B cell differentiation involved in immune response (GO:0002313) | 2.43486152 |
| 87 | retrograde transport, endosome to Golgi (GO:0042147) | 2.42810404 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.42415668 |
| 89 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.42205848 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.42147731 |
| 91 | type I interferon signaling pathway (GO:0060337) | 2.41180629 |
| 92 | cellular response to type I interferon (GO:0071357) | 2.41180629 |
| 93 | regulation of necroptotic process (GO:0060544) | 2.39418447 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.38762333 |
| 95 | protein dealkylation (GO:0008214) | 2.38672838 |
| 96 | protein demethylation (GO:0006482) | 2.38672838 |
| 97 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.38064367 |
| 98 | stress fiber assembly (GO:0043149) | 2.37882998 |
| 99 | endothelial cell chemotaxis (GO:0035767) | 2.37418980 |
| 100 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.36499502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.53746840 |
| 2 | * MYC_22102868_ChIP-Seq_BL_Human | 3.12143184 |
| 3 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.99292083 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.98082454 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.79636707 |
| 6 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.68588157 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.52013193 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.47919934 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.34762581 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25591821 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19171845 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19168010 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15449755 |
| 14 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.06271748 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02945701 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.01385856 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 1.98943176 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98000484 |
| 19 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97382204 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96869184 |
| 21 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96091751 |
| 22 | KDM2B_26808549_Chip-Seq_K562_Human | 1.86818664 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84573127 |
| 24 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.83586467 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83259024 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83130692 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78860890 |
| 28 | * P68_20966046_ChIP-Seq_HELA_Human | 1.78074880 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.76860098 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76557713 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71085409 |
| 32 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.64476297 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64391562 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64238488 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59942833 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59490566 |
| 37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58079428 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56872964 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55515104 |
| 40 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54796689 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54335833 |
| 42 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.53504434 |
| 43 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49907032 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49823072 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46430068 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45210854 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45129404 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44732484 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44649760 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44300188 |
| 51 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.43323807 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40983636 |
| 53 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.38479642 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37929013 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36367716 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34062435 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33500640 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33282231 |
| 59 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33273926 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32978942 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32642296 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32234828 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30665966 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30450510 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29722877 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29384194 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26644011 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25081305 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18119820 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18093645 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18049338 |
| 72 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16109607 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15855468 |
| 74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15457638 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14620798 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14617188 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.14195159 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13825205 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13789671 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13587534 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12342570 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09818911 |
| 83 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09397056 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09324459 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09052909 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06617491 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06133677 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05565672 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04916936 |
| 90 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04877824 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.04384028 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04264980 |
| 93 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04252473 |
| 94 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03916766 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03540360 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03536256 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03258503 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02429980 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00813703 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00002264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.81709438 |
| 2 | MP0003303_peritoneal_inflammation | 3.36216192 |
| 3 | MP0009278_abnormal_bone_marrow | 3.35536650 |
| 4 | MP0005451_abnormal_body_composition | 3.20710387 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.14754161 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.85029530 |
| 7 | MP0005076_abnormal_cell_differentiation | 2.66627628 |
| 8 | MP0004947_skin_inflammation | 2.49767741 |
| 9 | MP0008260_abnormal_autophagy | 2.45294117 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.41109442 |
| 11 | MP0004510_myositis | 2.34601386 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.16014123 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.14637970 |
| 14 | MP0002419_abnormal_innate_immunity | 2.09702244 |
| 15 | MP0001790_abnormal_immune_system | 2.09590214 |
| 16 | MP0005387_immune_system_phenotype | 2.09590214 |
| 17 | MP0000685_abnormal_immune_system | 2.08831514 |
| 18 | MP0005025_abnormal_response_to | 2.08688505 |
| 19 | MP0001800_abnormal_humoral_immune | 2.06541450 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.96013398 |
| 21 | MP0009840_abnormal_foam_cell | 1.93859573 |
| 22 | MP0005671_abnormal_response_to | 1.92818733 |
| 23 | MP0002723_abnormal_immune_serum | 1.85330891 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.84235634 |
| 25 | MP0001819_abnormal_immune_cell | 1.83274558 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.82672621 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.81869853 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.77422112 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.76670685 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.72618322 |
| 31 | MP0004858_abnormal_nervous_system | 1.71899196 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.67305385 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.63048791 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.63048791 |
| 35 | MP0003724_increased_susceptibility_to | 1.58892312 |
| 36 | MP0002822_catalepsy | 1.56616804 |
| 37 | MP0001849_ear_inflammation | 1.55471881 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.53066770 |
| 39 | MP0000716_abnormal_immune_system | 1.51367369 |
| 40 | MP0002398_abnormal_bone_marrow | 1.50719152 |
| 41 | MP0002405_respiratory_system_inflammati | 1.46075144 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.45212431 |
| 43 | MP0002009_preneoplasia | 1.42807475 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.42602018 |
| 45 | MP0002653_abnormal_ependyma_morphology | 1.41417115 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.41098590 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.38224683 |
| 48 | MP0002933_joint_inflammation | 1.37716577 |
| 49 | MP0002722_abnormal_immune_system | 1.33776293 |
| 50 | MP0006082_CNS_inflammation | 1.32652734 |
| 51 | MP0001873_stomach_inflammation | 1.29633724 |
| 52 | MP0005310_abnormal_salivary_gland | 1.28843080 |
| 53 | MP0004381_abnormal_hair_follicle | 1.28269345 |
| 54 | MP0003329_amyloid_beta_deposits | 1.23093196 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.22801735 |
| 56 | MP0003866_abnormal_defecation | 1.21564281 |
| 57 | MP0002429_abnormal_blood_cell | 1.21082328 |
| 58 | MP0002796_impaired_skin_barrier | 1.21067759 |
| 59 | MP0009785_altered_susceptibility_to | 1.20744428 |
| 60 | MP0003690_abnormal_glial_cell | 1.20620517 |
| 61 | MP0000858_altered_metastatic_potential | 1.20355643 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.19159986 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.18310214 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.18087531 |
| 65 | MP0001851_eye_inflammation | 1.14872407 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.10638003 |
| 67 | MP0000604_amyloidosis | 1.09700148 |
| 68 | MP0003091_abnormal_cell_migration | 1.09211868 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.07914278 |
| 70 | MP0001853_heart_inflammation | 1.06813885 |
| 71 | MP0000678_abnormal_parathyroid_gland | 1.06374133 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.03765302 |
| 73 | MP0003075_altered_response_to | 0.98700963 |
| 74 | MP0000490_abnormal_crypts_of | 0.97738159 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.96760431 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.89529750 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.88691816 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.88547355 |
| 79 | MP0005409_darkened_coat_color | 0.85668198 |
| 80 | MP0003878_abnormal_ear_physiology | 0.85097793 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.85097793 |
| 82 | MP0002166_altered_tumor_susceptibility | 0.84385644 |
| 83 | MP0004859_abnormal_synaptic_plasticity | 0.83700346 |
| 84 | MP0008469_abnormal_protein_level | 0.83398967 |
| 85 | MP0002254_reproductive_system_inflammat | 0.83310255 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.82582834 |
| 87 | MP0003828_pulmonary_edema | 0.81985493 |
| 88 | MP0000751_myopathy | 0.81562611 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.79438177 |
| 90 | MP0009764_decreased_sensitivity_to | 0.76210733 |
| 91 | MP0004130_abnormal_muscle_cell | 0.75563529 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.73927213 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.73882697 |
| 94 | MP0005621_abnormal_cell_physiology | 0.72565284 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.72437263 |
| 96 | MP0003879_abnormal_hair_cell | 0.71362147 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.71165172 |
| 98 | MP0005390_skeleton_phenotype | 0.69874060 |
| 99 | MP0003045_fibrosis | 0.67689252 |
| 100 | MP0001663_abnormal_digestive_system | 0.67649946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.33525521 |
| 2 | Colitis (HP:0002583) | 3.84194379 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.42690186 |
| 4 | Broad face (HP:0000283) | 3.41824284 |
| 5 | Obstructive sleep apnea (HP:0002870) | 3.31256095 |
| 6 | Gastrointestinal inflammation (HP:0004386) | 3.20957755 |
| 7 | Increased IgE level (HP:0003212) | 3.07739238 |
| 8 | Recurrent abscess formation (HP:0002722) | 2.98877826 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 2.98016921 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 2.96391827 |
| 11 | Inflammation of the large intestine (HP:0002037) | 2.93707567 |
| 12 | Hyperacusis (HP:0010780) | 2.92655788 |
| 13 | Myositis (HP:0100614) | 2.92357687 |
| 14 | Cellulitis (HP:0100658) | 2.91411737 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.89555085 |
| 16 | Loss of speech (HP:0002371) | 2.83617633 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 2.79219267 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.78931247 |
| 19 | Thoracic kyphosis (HP:0002942) | 2.71342681 |
| 20 | Neuronal loss in central nervous system (HP:0002529) | 2.66721410 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.65576413 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 2.54681566 |
| 23 | Pustule (HP:0200039) | 2.49991153 |
| 24 | Gingivitis (HP:0000230) | 2.49014137 |
| 25 | Obstructive lung disease (HP:0006536) | 2.38276143 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38276143 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37236873 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36556973 |
| 29 | Flat acetabular roof (HP:0003180) | 2.36172379 |
| 30 | Abnormality of the thoracic spine (HP:0100711) | 2.33787823 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.31132270 |
| 32 | Thin bony cortex (HP:0002753) | 2.31014170 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30960317 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29286063 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27092329 |
| 36 | Recurrent viral infections (HP:0004429) | 2.23974358 |
| 37 | Meningitis (HP:0001287) | 2.22978666 |
| 38 | Metaphyseal cupping (HP:0003021) | 2.21988506 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.20940738 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.19103408 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19103408 |
| 42 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.16018617 |
| 43 | Abnormality of the columella (HP:0009929) | 2.14661644 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.14531541 |
| 45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14005762 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14005762 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14005762 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11614291 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11614291 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11614291 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.08174260 |
| 52 | Annular pancreas (HP:0001734) | 2.06744108 |
| 53 | Slow saccadic eye movements (HP:0000514) | 2.06627420 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.04229068 |
| 55 | Orchitis (HP:0100796) | 2.02554145 |
| 56 | Nasal polyposis (HP:0100582) | 2.01054550 |
| 57 | Hemorrhage of the eye (HP:0011885) | 1.94154519 |
| 58 | Emphysema (HP:0002097) | 1.93503914 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 1.92920805 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 1.91008725 |
| 61 | Neurofibrillary tangles (HP:0002185) | 1.90238128 |
| 62 | Recurrent skin infections (HP:0001581) | 1.88820019 |
| 63 | J-shaped sella turcica (HP:0002680) | 1.88690643 |
| 64 | Polygenic inheritance (HP:0010982) | 1.87152476 |
| 65 | Papilledema (HP:0001085) | 1.85938714 |
| 66 | Exercise-induced myalgia (HP:0003738) | 1.84105403 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 1.82177707 |
| 68 | Increased connective tissue (HP:0009025) | 1.80871007 |
| 69 | Peripheral hypomyelination (HP:0007182) | 1.79802919 |
| 70 | Axonal loss (HP:0003447) | 1.78909385 |
| 71 | Cervical subluxation (HP:0003308) | 1.78596177 |
| 72 | Difficulty climbing stairs (HP:0003551) | 1.78094403 |
| 73 | Spontaneous hematomas (HP:0007420) | 1.77791177 |
| 74 | Lymphopenia (HP:0001888) | 1.74082732 |
| 75 | Upper limb amyotrophy (HP:0009129) | 1.74026619 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 1.74026619 |
| 77 | Pointed chin (HP:0000307) | 1.73895572 |
| 78 | Distal lower limb muscle weakness (HP:0009053) | 1.73264351 |
| 79 | Bowel incontinence (HP:0002607) | 1.72832962 |
| 80 | Restrictive lung disease (HP:0002091) | 1.72434189 |
| 81 | Vasculitis (HP:0002633) | 1.71849611 |
| 82 | Easy fatigability (HP:0003388) | 1.71500041 |
| 83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71471384 |
| 84 | Ankle clonus (HP:0011448) | 1.71250701 |
| 85 | Hypertriglyceridemia (HP:0002155) | 1.70976446 |
| 86 | Optic neuritis (HP:0100653) | 1.70757390 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.70757390 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70735293 |
| 89 | Recurrent sinusitis (HP:0011108) | 1.70471482 |
| 90 | Amyloidosis (HP:0011034) | 1.70375808 |
| 91 | Stomatitis (HP:0010280) | 1.69382066 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 1.69258705 |
| 93 | Broad distal phalanx of finger (HP:0009836) | 1.69054403 |
| 94 | Nuclear cataract (HP:0100018) | 1.69046302 |
| 95 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69018612 |
| 96 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69018612 |
| 97 | Myopathic facies (HP:0002058) | 1.68834196 |
| 98 | Stridor (HP:0010307) | 1.66045729 |
| 99 | Sepsis (HP:0100806) | 1.65517976 |
| 100 | Growth hormone excess (HP:0000845) | 1.65153123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.73931743 |
| 2 | TRIB3 | 3.64220650 |
| 3 | MAP4K1 | 2.97583367 |
| 4 | ERN1 | 2.65866289 |
| 5 | SIK1 | 2.41941416 |
| 6 | RIPK4 | 2.37511115 |
| 7 | ICK | 2.29927326 |
| 8 | SMG1 | 2.23009326 |
| 9 | IRAK3 | 2.06580461 |
| 10 | EEF2K | 2.04553483 |
| 11 | TNK2 | 1.99429134 |
| 12 | MARK2 | 1.89356674 |
| 13 | EPHB1 | 1.88766463 |
| 14 | SIK2 | 1.84055972 |
| 15 | MAP2K3 | 1.72432467 |
| 16 | MAPK15 | 1.71950263 |
| 17 | TESK2 | 1.66508599 |
| 18 | TBK1 | 1.61690945 |
| 19 | TAOK1 | 1.54537975 |
| 20 | BLK | 1.53389130 |
| 21 | MAP3K10 | 1.53338192 |
| 22 | CDK12 | 1.52273585 |
| 23 | MAP3K14 | 1.47570227 |
| 24 | MAP3K13 | 1.39580625 |
| 25 | RIPK1 | 1.36790098 |
| 26 | TYK2 | 1.31568230 |
| 27 | PRKD2 | 1.28624102 |
| 28 | IRAK2 | 1.28395906 |
| 29 | TAOK2 | 1.27831586 |
| 30 | CDC42BPA | 1.26889547 |
| 31 | PKN2 | 1.24645684 |
| 32 | MAP3K11 | 1.24203591 |
| 33 | FGFR4 | 1.22997467 |
| 34 | MAP3K7 | 1.22316423 |
| 35 | SIK3 | 1.20762401 |
| 36 | NME2 | 1.20183732 |
| 37 | ZAP70 | 1.15774369 |
| 38 | FES | 1.15255203 |
| 39 | BTK | 1.15193915 |
| 40 | IRAK4 | 1.13897715 |
| 41 | CSK | 1.13647190 |
| 42 | DYRK1B | 1.13025352 |
| 43 | CAMKK1 | 1.07017996 |
| 44 | GRK6 | 1.03644877 |
| 45 | CSF1R | 1.02544989 |
| 46 | TTN | 1.01848430 |
| 47 | MAP3K6 | 1.01132138 |
| 48 | MAP3K3 | 1.01128879 |
| 49 | MAP3K1 | 0.93230409 |
| 50 | IKBKE | 0.92692201 |
| 51 | MAP2K2 | 0.90489086 |
| 52 | DDR2 | 0.88039067 |
| 53 | MAPK12 | 0.85294371 |
| 54 | FGR | 0.84777270 |
| 55 | HCK | 0.82830766 |
| 56 | RPS6KA2 | 0.82812430 |
| 57 | HIPK2 | 0.82302909 |
| 58 | RPS6KL1 | 0.82195122 |
| 59 | RPS6KC1 | 0.82195122 |
| 60 | BMX | 0.82021151 |
| 61 | MATK | 0.81974098 |
| 62 | MTOR | 0.80767557 |
| 63 | JAK3 | 0.76678930 |
| 64 | CDK4 | 0.73662740 |
| 65 | TESK1 | 0.71719336 |
| 66 | CAMK1D | 0.71133112 |
| 67 | SYK | 0.68549044 |
| 68 | MAPK11 | 0.67979278 |
| 69 | CAMK4 | 0.67814072 |
| 70 | PTK6 | 0.65213891 |
| 71 | PRKD3 | 0.65209821 |
| 72 | PDPK1 | 0.64925617 |
| 73 | PDK1 | 0.63985854 |
| 74 | RPS6KA6 | 0.63948368 |
| 75 | JAK1 | 0.63445708 |
| 76 | IKBKB | 0.62435370 |
| 77 | EPHA2 | 0.60034422 |
| 78 | CDK6 | 0.56062719 |
| 79 | CHUK | 0.53796056 |
| 80 | LCK | 0.53425309 |
| 81 | ITK | 0.53375162 |
| 82 | JAK2 | 0.51345350 |
| 83 | KIT | 0.50439414 |
| 84 | TYRO3 | 0.50273909 |
| 85 | MAP2K6 | 0.49824316 |
| 86 | BRAF | 0.49523782 |
| 87 | MAPK4 | 0.49404366 |
| 88 | MAPK7 | 0.49059365 |
| 89 | KSR2 | 0.45877119 |
| 90 | RET | 0.45437651 |
| 91 | LYN | 0.45109819 |
| 92 | ARAF | 0.44979918 |
| 93 | LRRK2 | 0.40072644 |
| 94 | PASK | 0.39292000 |
| 95 | RPS6KA1 | 0.39082622 |
| 96 | FYN | 0.38850868 |
| 97 | PAK4 | 0.37892974 |
| 98 | UHMK1 | 0.36679035 |
| 99 | MAPKAPK2 | 0.36393979 |
| 100 | PDGFRA | 0.34826886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.26475345 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.25940790 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.12195158 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06950836 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03959359 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.93696126 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82323752 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77052691 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75141859 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66201927 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61377751 |
| 12 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.59273949 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56763234 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.45627066 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39841163 |
| 16 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.38072611 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.34689602 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31403850 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30865762 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30521108 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.29991461 |
| 22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28398097 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26760121 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24844412 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20483085 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19821055 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16526201 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.15596830 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14256649 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.13328933 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10335052 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09353249 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08102229 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.06526422 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06520807 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06271109 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05689324 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05521534 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04814821 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.02277162 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01485512 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01171423 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00293664 |
| 44 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00190826 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99716397 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98793274 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98002005 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 0.97949574 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96122046 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95911583 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95489777 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.91840269 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90849514 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89357058 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.88745543 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88161463 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87344175 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.85334828 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.85329364 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.85039792 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84736697 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84291523 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83550442 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.82959719 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82821714 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77828922 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77333721 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77307527 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76041747 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75929992 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.75638664 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75418225 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.75397304 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.75166572 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74980903 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74351113 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72540983 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70892921 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69076992 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68918619 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68368157 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.67300374 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66881190 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66728942 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66323469 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.65783693 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.65584416 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65244855 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.65241597 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65139156 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64759547 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.64108543 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63926568 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62778027 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62621676 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62055723 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.60967474 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58682190 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58048453 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.54874026 |

